Carbamazepine and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Reduced rivaroxaban exposure from enzyme induction
Carbamazepine is a strong enzyme inducer and can reduce DOAC concentrations. This may compromise anticoagulant efficacy and requires specialist review. In this scenario, the correct option is reduced rivaroxaban exposure from enzyme induction. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions